Olivier Taelman is an experienced MedTech leader, joining Nyxoah in July 2019 as Chief Operating and Commercial Officer and subsequently being appointed as CEO in November 2019.  Olivier spent 7 years in commercial healthcare at Eli Lilly and Sanofi Aventis leading specific Business Units. He spent 15 years within the field of neuromodulation at Medtronic, managing EMEA at Stryker NeuroVascular and serving a neuromodulation company Nevro where he was responsible for building the European business during the successful NASDAQ IPO.

Fabian Suarez Gonzalez is the Company's CFO. He joined Nyxoah in 2014 to take the leadership of the finance department. He is an experienced executive, having held senior roles in several private equity firms between 2005 and 2014. For five years he was CFO of TTR Energy, an investment vehicle which co-managed several private equity funds for which he supervised due diligence processes related to acquisitions and asset sales. Prior to this, he served as consultant for major financial conglomerates in matters related to risk and asset management.

Rémi Renard has 15 years of experience in Sales and Marketing.  Throughout his career he has held multiple sales and marketing positions in medical device firms, mostly in the Cardiac Rhythm Management and OSA fields at Resmed, Boston Scientific and St. Jude Medical. Notably he successfully led sales and marketing activities related to the introduction in international markets of the first to market leadless pacemaker.

Guillaume Raux has 15 years of clinical affairs experience both in managing the back office and in the field, mostly at St Jude Medical Inc. Throughout his career, he has held multiple positions ranging from Field Clinical Engineer to Director Clinical Affairs. He was in charge of managing the clinical operation of the first leadless pacemaker. He was instrumental in delivering key clinical data in some very early stage IDE projects.

Dorit has 13 years of experience in process manufacturing and quality management in highly regulated industries. She has successfully led both small and large groups in numerous manufacturing aspects including routine production, implementation of process changes, qualifications of new manufacturing sites and preparation to regulatory audits. She has extensive experience working in GMP and QSR/ISO 13485 regulated environments, including successful FDA, and EMA audits.

Dorit holds a MSc. in Food Engineering and Biotechnology from the Technion, Israel, a PhD in Integrative Biology from University of Texas Southwestern (UTSW) Medical Center Dallas, Texas, and an MBA from College of Management, Israel.

Roi has over 15 years of experience in research and development of multidisciplinary products, mainly in the medical field. Roi led multiple positions ranging from HW engineer through System, Project, and Program manager to Director of R&D and Engineering.

Roi’s background encompasses both engineering and development of products in a vast manifold of technologies specializes in Electrical, SW, and Mechanical design. Roi holds a B.Sc in Electrical and Computers Engineering from Ben-Gurion University in Beersheba, Israel.

Sandra has 9 years of experience in the medical device industry field, managing a full scope of Quality & Regulatory department and activities. Prior to Nyxoah, Sandra had led the Quality department in a Medtech company and led the quality system towards PMA process. Throughout her career she had successfully mastered regulatory, quality and clinical path of medical devices. She's fully proficient with international regulations and standards. Sandra holds a B.Eng (Biomedical) degree from TAU and a Masters degree from Technion.

Nathalie Gilat has over 14 years of experience in global clinical & regulatory affairs. When joining Nyxoah in 2014, Nathalie played a key role in its initial clinical studies obtaining CE mark and regulatory milestones in the US. Currently, Nathalie is leading the Israeli organization as General Manager. Prior to Nyxoah, Nathalie held various managerial roles in innovative medical device companies, such as Valtech Cardio (acquired by Edwards Lifesciences) and Ovalum vascular. Nathalie holds a Biomedical Engineering degree from Ben-Gurion University and an MBA from Tel Aviv University.